Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatography

Clin Biochem. 2012 Mar;45(4-5):293-7. doi: 10.1016/j.clinbiochem.2011.12.013. Epub 2012 Jan 3.

Abstract

Objective: To study size heterogeneity of triglyceride rich lipoproteins (TRL) in metabolic syndrome (MS).

Design and methods: Thirty MS patients and 14 healthy subjects were included. In fasting serum we measured: lipid profile, free fatty acids (FFA) and adiponectin; TRL were isolated (d<1.006 g/mL) and analysis by size exclusion HPLC followed by UV detection was performed; each subfraction was expressed as percentage of total TRL.

Results: MS patients, even those with normal triglycerides, presented higher proportion of very large VLDL (90 nm diameter) and large VLDL (60 nm) and slightly lower of typical VLDL (37 nm) (p<0.04); increased FFA (p=0.04) and lower adiponectin (p=0.001). FFA correlated with large VLDL% (r=0.58; p=0.003), independently of insulin-resistance and waist. Furthermore, the lower the adiponectin, the greater the predominance of large VLDL (r=-0.40; p=0.04).

Conclusion: MS was associated with large VLDL, described as more atherogenic beyond triglyceride levels. Size exclusion HPLC would represent a useful tool for assessing subfractions' lipoprotein profile.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiponectin / blood
  • Adult
  • Argentina / epidemiology
  • Atherosclerosis / epidemiology
  • Chromatography, Gel
  • Chromatography, High Pressure Liquid
  • Fatty Acids, Nonesterified / blood
  • Female
  • Humans
  • Lipoproteins, VLDL / blood*
  • Lipoproteins, VLDL / chemistry
  • Lipoproteins, VLDL / isolation & purification
  • Male
  • Metabolic Syndrome / blood*
  • Middle Aged
  • Particle Size
  • Risk
  • Triglycerides / blood
  • Ultracentrifugation

Substances

  • ADIPOQ protein, human
  • Adiponectin
  • Fatty Acids, Nonesterified
  • Lipoproteins, VLDL
  • Triglycerides
  • very low density lipoprotein triglyceride